Two Sigma Advisers, LP’s Dexcom Inc Position
Does Two Sigma Advisers, LP own Dexcom Inc (DC4)? Not currently — the last reported position was 748.1K shares worth $50M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$50M
Q4 2025
Shares
748.1K
% of Portfolio
+0.10%
Quarters Held
24
position exited
Position History DC4
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 748.1K | $50M | +0.10% |
| Q3 2025 | 386.3K | $26M | +0.05% |
| Q2 2025 | 13.7K | $1M | 0.00% |
| Q1 2025 | 599.1K | $41M | +0.09% |
| Q4 2024 | 1.24M | $97M | +0.22% |
| Q3 2024 | 1.14M | $77M | +0.18% |
| Q2 2024 | 404.5K | $46M | +0.10% |
| Q3 2023 | 56.5K | $5M | +0.01% |
| Q2 2023 | 317.1K | $41M | +0.10% |
| Q1 2023 | 501.6K | $58M | +0.15% |
| Q4 2022 | 70.7K | $8M | +0.02% |
| Q3 2022 | 255.4K | $21M | +0.06% |
| Q2 2022 | 1.10M | $82M | +0.23% |
| Q1 2022 | 256.5K | $131M | +0.35% |
| Q4 2021 | 441.4K | $237M | +0.59% |
| Q3 2021 | 5.7K | $3M | +0.01% |
| Q1 2021 | 4.3K | $2M | 0.00% |
| Q3 2020 | 131.1K | $54M | +0.15% |
| Q2 2020 | 130.8K | $53M | +0.15% |
| Q1 2020 | 106.0K | $29M | +0.11% |
| Q4 2019 | 40.0K | $9M | +0.02% |
| Q2 2019 | 419.1K | $63M | +0.16% |
| Q1 2019 | 551.9K | $66M | +0.17% |
| Q4 2018 | 694.8K | $83M | +0.23% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Sigma Advisers, LP’s full portfolio or all institutional holders of DC4.